Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2017 Feb 22;98(2):304–317. doi: 10.1016/j.ijrobp.2017.02.019

Table 5.

Brachytherapy only +/−NADT distribution of participant responses to EPIC Hormone/Vitality HRQOL items at baseline, 6, 12, and 24 months.

NADT No NADT P value*
How big a problem during the last 4 weeks, if any, has each of the following been for you? Moderate problem + Big problem No Problem + Very small problem + Small problem n Moderate problem + Big problem No Problem + Very small problem + Small problem n
Hot flashes[1] 0.1014
 Baseline: 0% 100% 14 0.7% 99.3% 270
 6 months: 15.4% 84.6% 13 2.4% 97.6% 253
 12 months: 0% 100% 12 0.8% 99.2% 250
 24 months: 8.3% 91.7% 12 1.3% 98.7% 233
Breast tenderness/enlargement[1] 0.7551
 Baseline: 0% 100% 14 0.7% 99.3% 270
 6 months: 7.7% 92.3% 13 1.2% 98.8% 253
 12 months: 0% 100% 12 0.8% 99.2% 250
 24 months: 0% 100% 12 0.9% 99.1% 233
Feeling depressed[1] 0.9208
 Baseline: 0% 100% 14 4.1% 95.9% 271
 6 months: 15.4% 84.6% 13 4.3% 95.7% 254
 12 months: 16.7% 83.3% 12 3.6% 96.4% 249
 24 months: 0% 100% 12 5.2% 94.9% 233
Lack of energy 0.3000
 Baseline: 7.1% 92.9% 14 6.7% 93.3% 270
 6 months: 30.8% 69.2% 13 15.8% 84.3% 254
 12 months: 8.3% 91.7% 12 14.4% 85.6% 250
 24 months: 8.3% 91.7% 12 11.6% 88.4% 233
Change in body weight[1] 0.0501
 Baseline: 0% 100% 14 3.0% 97.1% 271
 6 months: 30.8% 69.2% 13 5.9% 94.1% 254
 12 months: 16.7% 83.3% 12 7.6% 92.4% 249
 24 months: 8.3% 91.7% 12 6.0% 94.0% 233

P value reflects a test of the interaction term between group and the time points in linear generalized estimating equations (GEE).

[1]

Cochran-Mantel-Haenszel test